Work

Outcomes of transcatheter device closure of hemodynamically significant PDA in neonates weighing < 3 kilograms

Year: 2026
Type: preprint
Study design: Observational Study
Abstract: OBJECTIVES To demonstrate the safety and efficacy of transcatheter patent ductus arteriosus (PDA) device closure in neonates weighing ≤ 3 kilograms and to analyze its effect on respiratory status and growth. BACKGROUND Current management of hemodynamically significant PDA in premature neonates include medical closure, surgical ligation, and transcatheter device closure. Challenges include significant complications and, for medical closure, high failure rates. Techniques that increased complication risk impeded transcatheter methods. Increasing efforts at transcatheter closure are occurring, however, most are case reports and small, single center case series. METHODS From January 2015 to June 2019, all premature neonates ≤ 3 kg who underwent transcatheter PDA closure were retrospectively reviewed. RESULTS 94 device closures were performed on 91 patients with a median weight of 2.0 kg (0.90–3.0 kg). Procedural success was 99%. Complications included 3 device embolizations requiring retrieval. There was no procedural mortality. There was overall improvement in respiratory support represented by an average 0.17 decrease in the Pulmonary Score at a median of 69 days (1–333 days) (p = < 0.001). A corrected gestational age of < 34 weeks was associated with the highest proportion of patients with a decrease in Pulmonary Score. Growth velocity increased at four weeks post-procedure by 5.2 g/day (p = < 0.001) compared to two weeks pre-procedure. CONCLUSIONS With the availability of devices and techniques that enable delivery in small neonates, transcatheter PDA closure is an effective and low morbidity alternative to traditional therapies with improvement in respiratory status and growth.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7236736023
Cites: 25
Cited by:
Related to: 10